News from merrimack pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 01, 2004, 01:00 ET

Merrimack Pharmaceuticals Begins Exploratory Collaboration with Novartis Institutes for Biomedical Research

CAMBRIDGE, Mass., June 1 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., today announced that the Company has initiated an exploratory research...

May 04, 2004, 01:00 ET

Merrimack Pharmaceuticals Closes $28 Million Series C Financing Round

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that it has...

May 04, 2004, 01:00 ET

Merrimack Pharmaceuticals Welcomes Gary L. Crocker to the Board of Directors

CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that Gary L. Crocker has joined the company's board of...

Mar 25, 2004, 00:00 ET

Merrimack Pharmaceuticals Awarded Second SBIR Grant

CAMBRIDGE, Mass., March 25 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that it was awarded a Phase I Small Business...

Feb 04, 2004, 00:00 ET

Merrimack Pharmaceuticals Names Dr. Vincent F. Simmon as Chief Operating Officer

CAMBRIDGE, Mass., Feb. 4 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a biotechnology company focused on developing therapeutics in...

Jan 29, 2004, 00:00 ET

Merrimack Pharmaceuticals Awarded SBIR Grant for Cancer Drug Discovery

CAMBRIDGE, Mass., Jan. 29 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that it was awarded a Phase I Small Business...

Nov 19, 2003, 00:00 ET

Merrimack Pharmaceuticals Completes Dosing in Phase I Study of Immunomodulator, MM-093

CAMBRIDGE, Mass., Nov. 19 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the completion of dosing of all volunteers in the...

Jul 29, 2003, 01:00 ET

Merrimack Pharmaceuticals Initiates Phase I Study of Immunomodulator, MM-093

CAMBRIDGE, Mass., July 29 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the initiation of a Phase I study for its...

Apr 02, 2002, 00:00 ET

Merrimack Pharmaceuticals Names Dr. Mark H. Perrone Vice President of Research And Development

CAMBRIDGE, Mass., April 2 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced that Mark H. Perrone, Ph.D., has joined the company as...

Mar 26, 2002, 00:00 ET

Merrimack Pharmaceuticals Elects Gary Frashier As Chairman of the Board of Directors

CAMBRIDGE, Mass., March 26 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the election of Gary Frashier as chairman of...

Mar 19, 2002, 00:00 ET

Merrimack Pharmaceuticals Welcomes Robert H. Rubin, MD to the Board of Directors

CAMBRIDGE, Mass., March 19 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. today announced the election of Robert H. Rubin, MD to the company's...

Feb 26, 2002, 00:00 ET

U.S. Composition-of-Matter Patent Secures Merrimack Pharmaceuticals' Rights to Recombinant Human Alpha Fetoprotein

CAMBRIDGE, Mass., Feb. 26 /PRNewswire/ -- Merrimack Pharmaceuticals announced today that the U.S. Patent and Trademark Office has issued a...

Feb 20, 2002, 00:00 ET

Merger Closes Between Merrimack Pharmaceuticals and Atlantic Biopharmaceuticals

CAMBRIDGE, Mass., Feb. 20 /PRNewswire/ -- Atlantic BioPharmaceuticals, Inc. (ABI), an immunology-focused drug development company, and Merrimack...